Reversing tolerance in isotype switch-competent anti-insulin B lymphocytes

Journal of Immunology

Volumn 195, Issue 3, 2015, Pages 853-864

  Williams, Jonathan M ^a   Bonami, Rachel H ^a   Hulbert, Chrys ^a   Thomas, James W ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN M; INSULIN ANTIBODY; AUTOANTIBODY; IMMUNOGLOBULIN G; INSULIN; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE; BRUCELLA ABORTUS; CLONAL VARIATION; CONTROLLED STUDY; FEMALE; GENE REARRANGEMENT; GERMINAL CENTER; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; IN VITRO STUDY; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; AUTOIMMUNITY; BIOSYNTHESIS; C57BL MOUSE; GENETICS; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; MOLECULAR GENETICS; TRANSGENIC MOUSE; VDJ EXON;

ANIMALS; ANTIGENS, CD40; AUTOANTIBODIES; AUTOIMMUNITY; B-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; IMMUNE TOLERANCE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INSULIN; INSULIN ANTIBODIES; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; VDJ EXONS;

EID: 84937687488     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1403114     Document Type: Article

References (64)

1. Pelanda, R., and R. M. Torres. 2012. Central B-cell tolerance: where selection begins. Cold Spring Harb. Perspect. Biol. 4: a007146.
2. Casellas, R., T. A. Shih, M. Kleinewietfeld, J. Rakonjac, D. Nemazee, K. Rajewsky, and M. C. Nussenzweig. 2001. Contribution of receptor editing to the antibody repertoire. Science 291: 1541-1544.
3. Radic, M. Z., J. Erikson, S. Litwin, and M. Weigert. 1993. B lymphocytes may escape tolerance by revising their antigen receptors. J. Exp. Med. 177: 1165-1173.
4. Nemazee, D., and K. Buerki. 1989. Clonal deletion of autoreactive B lymphocytes in bone marrow chimeras. Proc. Natl. Acad. Sci. USA 86: 8039-8043.
5. Chen, C., Z. Nagy, E. L. Prak, and M. Weigert. 1995. Immunoglobulin heavy chain gene replacement: a mechanism of receptor editing. Immunity 3: 747-755.
6. Cambier, J. C., S. B. Gauld, K. T. Merrell, and B. J. Vilen. 2007. B-cell anergy: from transgenic models to naturally occurring anergic B cells? Nat. Rev. Immunol. 7: 633-643.
7. Yarkoni, Y., A. Getahun, and J. C. Cambier. 2010. Molecular underpinning of B-cell anergy. Immunol. Rev. 237: 249-263.
8. Sakaguchi, S., K. Wing, Y. Onishi, P. Prieto-Martin, and T. Yamaguchi. 2009. Regulatory T cells: how do they suppress immune responses? Int. Immunol. 21: 1105-1111.
9. Kim, J., K. Lahl, S. Hori, C. Loddenkemper, A. Chaudhry, P. deRoos, A. Rudensky, and T. Sparwasser. 2009. Cutting edge: depletion of Foxp3+ cells leads to induction of autoimmunity by specific ablation of regulatory T cells in genetically targeted mice. J. Immunol. 183: 7631-7634.
10. Goodnow, C. C., J. Crosbie, S. Adelstein, T. B. Lavoie, S. J. Smith-Gill, R. A. Brink, H. Pritchard-Briscoe, J. S. Wotherspoon, R. H. Loblay, K. Raphael, et al. 1988. Altered immunoglobulin expression and functional silencing of selfreactive B lymphocytes in transgenic mice. Nature 334: 676-682.
11. Goodnow, C. C., J. Crosbie, H. Jorgensen, R. A. Brink, and A. Basten. 1989. Induction of self-tolerance in mature peripheral B lymphocytes. Nature 342: 385-391.
12. Getahun, A., S. K. O'Neill, and J. C. Cambier. 2009. Establishing anergy as a bona fide in vivo mechanism of B cell tolerance. J. Immunol. 183: 5439-5441.
13. Merrell, K. T., R. J. Benschop, S. B. Gauld, K. Aviszus, D. Decote-Ricardo, L. J. Wysocki, and J. C. Cambier. 2006. Identification of anergic B cells within a wild-type repertoire. Immunity 25: 953-962.
14. Hikida, M., and T. Kurosaki. 2005. Regulation of phospholipase C-g2 networks in B lymphocytes. Adv. Immunol. 88: 73-96.
15. Fruman, D. A., and G. Bismuth. 2009. Fine tuning the immune response with PI3K. Immunol. Rev. 228: 253-272.
16. Menard, L., D. Saadoun, I. Isnardi, Y. S. Ng, G. Meyers, C. Massad, C. Price, C. Abraham, R. Motaghedi, J. H. Buckner, et al. 2011. The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans. J. Clin. Invest. 121: 3635-3644.
17. Avalos, A. M., L. Busconi, and A. Marshak-Rothstein. 2010. Regulation of autoreactive B cell responses to endogenous TLR ligands. Autoimmunity 43: 76-83.
18. Avalos, A. M., M. B. Uccellini, P. Lenert, G. A. Viglianti, and A. Marshak-Rothstein. 2010. FcgRIIB regulation of BCR/TLR-dependent autoreactive B-cell responses. Eur. J. Immunol. 40: 2692-2698.
19. Maglione, P. J., N. Simchoni, S. Black, L. Radigan, J. R. Overbey, E. Bagiella, J. B. Bussel, X. Bossuyt, J. L. Casanova, I. Meyts, et al. 2014. IRAK-4 and MyD88 deficiencies impair IgM responses against T-independent bacterial antigens. Blood 124: 3561-3571.
20. Dye, J. R., A. Palvanov, B. Guo, and T. L. Rothstein. 2007. B cell receptor crosstalk: exposure to lipopolysaccharide induces an alternate pathway for B cell receptor-induced ERK phosphorylation and NF-kB activation. J. Immunol. 179: 229-235.
21. Kendall, P. L., G. Yu, E. J. Woodward, and J. W. Thomas. 2007. Tertiary lymphoid structures in the pancreas promote selection of B lymphocytes in autoimmune diabetes. J. Immunol. 178: 5643-5651.
22. Kendall, P. L., J. B. Case, A. M. Sullivan, J. S. Holderness, K. S. Wells, E. Liu, and J. W. Thomas. 2013. Tolerant anti-insulin B cells are effective APCs. J. Immunol. 190: 2519-2526.
23. Yalow, R. S., and S. A. Berson. 1960. Immunoassay of endogenous plasma insulin in man. J. Clin. Invest. 39: 1157-1175.
24. Schroer, J. A., J. K. Inman, J. W. Thomas, and A. S. Rosenthal. 1979. H-2-linked Ir gene control of antibody responses to insulin. I. Anti-insulin plaque-forming cell primary responses. J. Immunol. 123: 670-675.
25. Rojas, M., C. Hulbert, and J. W. Thomas. 2001. Anergy and not clonal ignorance determines the fate of B cells that recognize a physiological autoantigen. J. Immunol. 166: 3194-3200.
26. Acevedo-Suárez, C. A., C. Hulbert, E. J. Woodward, and J. W. Thomas. 2005. Uncoupling of anergy from developmental arrest in anti-insulin B cells supports the development of autoimmune diabetes. J. Immunol. 174: 827-833.
27. Koczwara, K., M. Schenker, S. Schmid, K. Kredel, A. G. Ziegler, and E. Bonifacio. 2003. Characterization of antibody responses to endogenous and exogenous antigen in the nonobese diabetic mouse. Clin. Immunol. 106: 155-162.
28. Boes, M., T. Schmidt, K. Linkemann, B. C. Beaudette, A. Marshak-Rothstein, and J. Chen. 2000. Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc. Natl. Acad. Sci. USA 97: 1184-1189.
29. Hoppu, S., M. S. Ronkainen, T. Kimpimäki, S. Simell, S. Korhonen, J. Ilonen, O. Simell, and M. Knip. 2004. Insulin autoantibody isotypes during the prediabetic process in young children with increased genetic risk of type 1 diabetes. Pediatr. Res. 55: 236-242.
30. Hahn, B. H. 1998. Antibodies to DNA. N. Engl. J. Med. 338: 1359-1368.
31. Zhang, L., M. Nakayama, and G. S. Eisenbarth. 2008. Insulin as an autoantigen in NOD/human diabetes. Curr. Opin. Immunol. 20: 111-118.
32. Nakayama, M. 2011. Insulin as a key autoantigen in the development of type 1 diabetes. Diabetes Metab. Res. Rev. 27: 773-777.
33. Thomas, J. W., R. P. Bucy, and J. A. Kapp. 1982. T cell-independent responses to an Ir gene-controlled antigen. I. Characteristics of the immune response to insulin complexed to Brucella abortus. J. Immunol. 129: 6-10.
34. Pewzner-Jung, Y., D. Friedmann, E. Sonoda, S. Jung, K. Rajewsky, and D. Eilat. 1998. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain. J. Immunol. 161: 4634-4645.
35. Henry-Bonami, R. A., J. M. Williams, A. B. Rachakonda, M. Karamali, P. L. Kendall, and J. W. Thomas. 2013. B lymphocyte "original sin" in the bone marrow enhances islet autoreactivity in type 1 diabetes-prone nonobese diabetic mice. J. Immunol. 190: 5992-6003.
36. Thomas, J. W., V. J. Virta, and L. J. Nell. 1986. Idiotypic determinants on human anti-insulin antibodies are cyclically expressed. J. Immunol. 137: 1610-1615.
37. Woodward, E. J., and J. W. Thomas. 2005. Multiple germline k light chains generate anti-insulin B cells in nonobese diabetic mice. J. Immunol. 175: 1073-1079.
38. Henry, R. A., P. L. Kendall, E. J. Woodward, C. Hulbert, and J. W. Thomas. 2010. Vk polymorphisms in NOD mice are spread throughout the entire immunoglobulin kappa locus and are shared by other autoimmune strains. Immunogenetics 62: 507-520.
39. Phan, T. G., M. Amesbury, S. Gardam, J. Crosbie, J. Hasbold, P. D. Hodgkin, A. Basten, and R. Brink. 2003. B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells. J. Exp. Med. 197: 845-860.
40. Liu, Z., and A. Davidson. 2011. BAFF and selection of autoreactive B cells. Trends Immunol. 32: 388-394.
41. Enzler, T., G. Bonizzi, G. J. Silverman, D. C. Otero, G. F. Widhopf, A. Anzelon-Mills, R. C. Rickert, and M. Karin. 2006. Alternative and classical NF-kB signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease. Immunity 25: 403-415.
42. Gavin, A. L., K. Hoebe, B. Duong, T. Ota, C. Martin, B. Beutler, and D. Nemazee. 2006. Adjuvant-enhanced antibody responses in the absence of Toll-like receptor signaling. Science 314: 1936-1938.
43. Mond, J. J., I. Scher, D. E. Mosier, M. Baese, and W. E. Paul. 1978. T-independent responses in B cell-defective CBA/N mice to Brucella abortus and to trinitrophenyl (TNP) conjugates of Brucella abortus. Eur. J. Immunol. 8: 459-463.
44. Gitlin, A. D., Z. Shulman, and M. C. Nussenzweig. 2014. Clonal selection in the germinal centre by regulated proliferation and hypermutation. Nature 509: 637-640.
45. Baumjohann, D., S. Preite, A. Reboldi, F. Ronchi, K. M. Ansel, A. Lanzavecchia, and F. Sallusto. 2013. Persistent antigen and germinal center B cells sustain T follicular helper cell responses and phenotype. Immunity 38: 596-605.
46. Qi, H., J. L. Cannons, F. Klauschen, P. L. Schwartzberg, and R. N. Germain. 2008. SAP-controlled T-B cell interactions underlie germinal centre formation. Nature 455: 764-769.
47. Fagarasan, S., and T. Honjo. 2000. T-Independent immune response: new aspects of B cell biology. Science 290: 89-92.
48. de Vinuesa, C. G., M. C. Cook, J. Ball, M. Drew, Y. Sunners, M. Cascalho, M. Wabl, G. G. Klaus, and I. C. MacLennan. 2000. Germinal centers without T cells. J. Exp. Med. 191: 485-494.
49. Wang, D., S. M. Wells, A. M. Stall, and E. A. Kabat. 1994. Reaction of germinal centers in the T-cell-independent response to the bacterial polysaccharide alpha (1→6)dextran. Proc. Natl. Acad. Sci. USA 91: 2502-2506.
50. Ewulonu, U. K., L. J. Nell, and J. W. Thomas. 1990. VH and VL gene usage by murine IgG antibodies that bind autologous insulin. J. Immunol. 144: 3091-3098.
51. Hartley, S. B., J. Crosbie, R. Brink, A. B. Kantor, A. Basten, and C. C. Goodnow. 1991. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature 353: 765-769.
52. Wang, H., and M. J. Shlomchik. 1997. High affinity rheumatoid factor transgenic B cells are eliminated in normal mice. J. Immunol. 159: 1125-1134.
53. Cyster, J. G., S. B. Hartley, and C. C. Goodnow. 1994. Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire. Nature 371: 389-395.
54. Endres, R. O., E. Kushnir, J. W. Kappler, P. Marrack, and S. C. Kinsky. 1983. A requirement for nonspecific T cell factors in antibody responses to "T cell independent" antigens. J. Immunol. 130: 781-784.
55. Kouskoff, V., G. Lacaud, and D. Nemazee. 2000. T cell-independent rescue of B lymphocytes from peripheral immune tolerance. Science 287: 2501-2503.
56. Caucheteux, S. M., C. Vernochet, J. Wantyghem, M. C. Gendron, and C. Kanellopoulos-Langevin. 2008. Tolerance induction to self-MHC antigens in fetal and neonatal mouse B cells. Int. Immunol. 20: 11-20.
57. Mohan, J. F., M. G. Levisetti, B. Calderon, J. W. Herzog, S. J. Petzold, and E. R. Unanue. 2010. Unique autoreactive T cells recognize insulin peptides generated within the islets of Langerhans in autoimmune diabetes. Nat. Immunol. 11: 350-354.
58. Levin, C., H. Perrin, and B. Combadiere. 2015. Tailored immunity by skin antigen-presenting cells. Hum. Vaccin. Immunother. 11: 27-36.
59. Soni, C., E. B. Wong, P. P. Domeier, T. N. Khan, T. Satoh, S. Akira, and Z. S. Rahman. 2014. B cell-intrinsic TLR7 signaling is essential for the development of spontaneous germinal centers. J. Immunol. 193: 4400-4414.
60. Christensen, S. R., M. Kashgarian, L. Alexopoulou, R. A. Flavell, S. Akira, and M. J. Shlomchik. 2005. Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J. Exp. Med. 202: 321-331.
61. Pone, E. J., J. Zhang, T. Mai, C. A. White, G. Li, J. K. Sakakura, P. J. Patel, A. Al-Qahtani, H. Zan, Z. Xu, and P. Casali. 2012. BCR-signalling synergizes with TLR-signalling for induction of AID and immunoglobulin class-switching through the non-canonical NF-kB pathway. Nat. Commun. 3: 767.
62. Forestier, C., E. Moreno, S. Méresse, A. Phalipon, D. Olive, P. Sansonetti, and J. P. Gorvel. 1999. Interaction of Brucella abortus lipopolysaccharide with major histocompatibility complex class II molecules in B lymphocytes. Infect. Immun. 67: 4048-4054.
63. Betts, M., P. Beining, M. Brunswick, J. Inman, R. D. Angus, T. Hoffman, and B. Golding. 1993. Lipopolysaccharide from Brucella abortus behaves as a T-cell-independent type 1 carrier in murine antigen-specific antibody responses. Infect. Immun. 61: 1722-1729.
64. Weiss, D. S., K. Takeda, S. Akira, A. Zychlinsky, and E. Moreno. 2005. MyD88, but not Toll-like receptors 4 and 2, is required for efficient clearance of Brucella abortus. Infect. Immun. 73: 5137-5143.